323 related articles for article (PubMed ID: 16716349)
1. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
4. Effects of bone morphogenetic protein 2 on Id expression and neuroblastoma cell differentiation.
Du Y; Yip H
Differentiation; 2010 Feb; 79(2):84-92. PubMed ID: 19889495
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
Upton PD; Long L; Trembath RC; Morrell NW
Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development.
Alejandre-Alcázar MA; Shalamanov PD; Amarie OV; Sevilla-Pérez J; Seeger W; Eickelberg O; Morty RE
Dev Dyn; 2007 Oct; 236(10):2825-35. PubMed ID: 17823941
[TBL] [Abstract][Full Text] [Related]
7. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
8. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.
Sivertsen EA; Huse K; Hystad ME; Kersten C; Smeland EB; Myklebust JH
Eur J Immunol; 2007 Oct; 37(10):2937-48. PubMed ID: 17899540
[TBL] [Abstract][Full Text] [Related]
10. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription.
Ho CC; Zhou X; Mishina Y; Bernard DJ
Mol Cell Endocrinol; 2011 Jan; 332(1-2):242-52. PubMed ID: 21056086
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway.
Tanikawa R; Tanikawa T; Hirashima M; Yamauchi A; Tanaka Y
Biochem Biophys Res Commun; 2010 Apr; 394(2):317-22. PubMed ID: 20206131
[TBL] [Abstract][Full Text] [Related]
13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.
Scharpfenecker M; Kruse JJ; Sprong D; Russell NS; Ten Dijke P; Stewart FA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):506-13. PubMed ID: 19147015
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
16. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
17. Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos.
He C; Chen X
Biochem Biophys Res Commun; 2005 Apr; 329(1):324-30. PubMed ID: 15721310
[TBL] [Abstract][Full Text] [Related]
18. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
19. Endofin acts as a Smad anchor for receptor activation in BMP signaling.
Shi W; Chang C; Nie S; Xie S; Wan M; Cao X
J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
